Study of Arm and Putter Movement in Golfers With Golfer's Cramp

Occupational; Cramp(s) Clinical Trial

Official title:

Golfer&Apos;s Cramp: Correlation of Wrist Movements and Surface EMG With Putter Movements

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02032758
• Other study ID #: 12-007930
• Status: Completed
• Phase: Phase 4
• First received: January 2, 2014
• Last updated: April 7, 2015
• Start date: January 2014
• Est. completion date: January 2015

Study information

• Verified date: April 2015
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug Administration
• Study type: Interventional

Clinical Trial Summary

The investigators will investigate golfers with visual evidence of an involuntary movement while putting before and after treatment with a low dose of propranolol.

Description:

Golfers who have evidence of golfers cramp will putt a series of putts during which they will be monitored for arm movements and putter movements. They will then be treated with a low dose of propranolol to see if there is a change in these parameters.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 26
• Est. completion date: January 2015
• Est. primary completion date: January 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 75 Years

Eligibility

Inclusion criteria:

• Age 18-75

• Complaint of golfer's cramp/yips

• Visual evidence of a movement disorder during putting

• Able to complete 80 putts during the session

Exclusion criteria:

• Contraindication to treatment with propranolol

• Movement disorder not when putting

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Dystonic Disorders
• Muscle Cramp
• Occupational; Cramp(s)
• Spasm

Intervention

Drug:
• Propranolol
Single oral dose of propranolol

Locations

Country	Name	City	State
United States	Mayo Clinic in Arizona	Scottsdale	Arizona

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Putter movement	Determine if putter movement changes after treatment	approximately 3 hours	No